Tokyo, Oct. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063122) titled 'Verification of the effects of wearing pantyliners with different specifications on subjective usability and physiological indices in healthy adult females' on Oct. 8.

Study Type: Interventional

Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Open -no one is blinded Control - No treatment

Primary Sponsor: Institute - KOBAYASHI Pharmaceutical Co., Ltd.

Condition: Condition - Healthy adults Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To verify whether differences occur in subjective comfort and physiological indices during wearing and exercising with panty liners of different specifications in healthy adult females. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Put on a pantyliner (A) and perform a walking test. Interventions/Control_2 - Put on a pantyliner (B) and perform a walking test.

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Female Key inclusion criteria - 1)Healthy female university students aged 18 and older 2)Non-smokers 3)Individuals who are not receiving outpatient treatment or medical care for hypertension, diabetes, psychiatric disorders, sleep disorders, or serious diseases 4)Individuals who gave written informed consent voluntarily after receiving explanation and fully understanding the study upon participation Key exclusion criteria - 1)Heavy alcohol drinkers (average pure alcohol intake of 60 g or more per day) 2)Individuals who have received hormone replacement therapy within the past year or are taking oral contraceptives 3)Individuals with extremely irregular eating habits, shift workers, night-shift workers, or those with irregular life rhythms 4)Individuals who routinely consume medicines or health foods aimed at stress reduction or blood flow improvement (guideline: 3 times or more per week) and cannot stop after consenting 5)Individuals with skin troubles in the delicate zone 6)Individuals who may show an allergic reaction to the test product 7)Individuals with a history or current medical condition causing abnormal vaginal discharge 8)Individuals who are pregnant, planning to become pregnant, or lactating 9)Individuals with irregular menstruation (guideline: average menstrual cycle of 24 days or less, or 39 days or more) 10)Individuals who plan to significantly alter their lifestyle habits during the study period, such as long-term travel 11)Individuals expected to undergo major changes or stressful situations in home or school environments 12)Individuals currently participating in other clinical trials, within 4 weeks after trial completion, or planning to participate in other clinical trials after consenting to this study 13)Other individuals deemed inappropriate as study subjects by the principal investigator Target Size - 20

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 09 Month 24 Day Date of IRB - 2026 Year 09 Month 24 Day Anticipated trial start date - 2026 Year 10 Month 08 Day Last follow-up date - 2027 Year 01 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072256

Disclaimer: Curated by HT Syndication.